JP2001520644A - カルニチン化合物およびdheaまたはdhea−sを含む造骨促進製剤 - Google Patents
カルニチン化合物およびdheaまたはdhea−sを含む造骨促進製剤Info
- Publication number
- JP2001520644A JP2001520644A JP54369198A JP54369198A JP2001520644A JP 2001520644 A JP2001520644 A JP 2001520644A JP 54369198 A JP54369198 A JP 54369198A JP 54369198 A JP54369198 A JP 54369198A JP 2001520644 A JP2001520644 A JP 2001520644A
- Authority
- JP
- Japan
- Prior art keywords
- carnitine
- dhea
- alkanoyl
- carbon atoms
- dehydroepiandrosterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 仮骨の形成の促進、および骨折の治癒に好適で、有効成分としてアルカノ イルL-カルニチン(直鎖状または分岐状アルカノイルは2-8炭素原子、好ましく は2-6炭素原子を有する)、またはその製剤学上許容できる塩、およびデヒドロエ ピアンドロステロン若しくはデヒドロエピアンドロステロンサルフェート、およ び1またはそれ以上の製剤学上許容できる賦形剤を含有する、経口、非経口、腸 内または経皮投与が可能な製剤。 2. アルカノイルL-カルニチンが、アセチル、プロピオニル、ブチリル、バ レリルおよびイソバレリルL-カルニチンから成る群から選択される、請求項1 の製剤。 3. デヒドロエピアンドロステロン又はデヒドロエピアンドロステロンサルフ ェートのアルカノイルL-カルニチンに対する重量対重量比が0.001:1から 0.1:1の範囲にある、前記請求項のいずれかの組成物。 4. さらにビタミン、無機塩、抗酸化剤および植物繊維を含む前記請求項のい ずれかの組成物。 5. 経口、非経川腸内または局所使用のための、錠剤、カプセル、顆粒、粉末 またはアンプルの製剤に、固体、半固体、液体、半液体、粉末、顆粒またはリポ ゾームの形態で存在する、前記請求項のいずれかの組成物。 6. 仮骨の形成および骨折の治癒を促進するのに適した薬物を製造するための 、アルカノイルが2-8炭素原子、好ましくは2-6炭素原子を有するアルカノイルL -カルニチン若しくはその薬剤学上許容できる塩とヒドロエピアンドロステロン 若しくはヒドロエピアンドロステロンサルフェートとの調和的使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97A000217 | 1997-04-16 | ||
IT97RM000217A IT1291141B1 (it) | 1997-04-16 | 1997-04-16 | Composizione farmaceutica comprendente una alcanoil l-carnitina, atta a stimolare la moltiplicazione e la crescita degli osteoblasti |
PCT/IT1998/000076 WO1998046233A1 (en) | 1997-04-16 | 1998-04-03 | Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001520644A true JP2001520644A (ja) | 2001-10-30 |
Family
ID=11404977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54369198A Pending JP2001520644A (ja) | 1997-04-16 | 1998-04-03 | カルニチン化合物およびdheaまたはdhea−sを含む造骨促進製剤 |
Country Status (17)
Country | Link |
---|---|
US (1) | US6329358B1 (ja) |
EP (1) | EP0977576B1 (ja) |
JP (1) | JP2001520644A (ja) |
KR (1) | KR20010006465A (ja) |
AT (1) | ATE269707T1 (ja) |
AU (1) | AU730710B2 (ja) |
BR (1) | BR9809762A (ja) |
CA (1) | CA2286719C (ja) |
DE (1) | DE69824718T2 (ja) |
DK (1) | DK0977576T3 (ja) |
ES (1) | ES2224380T3 (ja) |
HK (1) | HK1025243A1 (ja) |
IT (1) | IT1291141B1 (ja) |
NZ (1) | NZ500533A (ja) |
PT (1) | PT977576E (ja) |
SI (1) | SI0977576T1 (ja) |
WO (1) | WO1998046233A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1317079B1 (it) | 2000-12-21 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi. |
US6911438B2 (en) * | 2001-09-12 | 2005-06-28 | Jonathan V. Wright | Hormone replacement formulation |
US20080069814A1 (en) * | 2005-01-05 | 2008-03-20 | Novacea, Inc. | Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof |
MX2007013029A (es) * | 2005-04-22 | 2008-01-11 | Novacea Inc | Tratamiento, prevencion y mejora de trastornos pulmonares asociados con la quimioterapia o radioterapia con compuestos activos de vitamina d o substancias mimeticas de los mismos. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05155766A (ja) * | 1991-06-05 | 1993-06-22 | Sigma Tau Ind Farmaceut Riunite Spa | 筋緊張力回復のためのアシル−l−カルニチン医薬組成物 |
WO1995005168A1 (en) * | 1993-08-19 | 1995-02-23 | Shug Austin L | Delayed release carnitine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5240961A (en) * | 1992-07-02 | 1993-08-31 | Shug Austin L | Method of treating reduced insulin-like growth factor and bone loss associated with aging |
US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
US5569457A (en) * | 1994-11-18 | 1996-10-29 | Shug; Austin L. | Method of stimulating antibody formation |
US5945412A (en) * | 1996-12-09 | 1999-08-31 | Merck & Co., Inc. | Methods and compositions for preventing and treating bone loss |
-
1997
- 1997-04-16 IT IT97RM000217A patent/IT1291141B1/it active IP Right Grant
-
1998
- 1998-04-03 DE DE69824718T patent/DE69824718T2/de not_active Expired - Lifetime
- 1998-04-03 KR KR1019997009555A patent/KR20010006465A/ko not_active Application Discontinuation
- 1998-04-03 DK DK98917594T patent/DK0977576T3/da active
- 1998-04-03 JP JP54369198A patent/JP2001520644A/ja active Pending
- 1998-04-03 NZ NZ500533A patent/NZ500533A/xx not_active IP Right Cessation
- 1998-04-03 AU AU70774/98A patent/AU730710B2/en not_active Ceased
- 1998-04-03 EP EP98917594A patent/EP0977576B1/en not_active Expired - Lifetime
- 1998-04-03 BR BR9809762-8A patent/BR9809762A/pt not_active IP Right Cessation
- 1998-04-03 WO PCT/IT1998/000076 patent/WO1998046233A1/en not_active Application Discontinuation
- 1998-04-03 ES ES98917594T patent/ES2224380T3/es not_active Expired - Lifetime
- 1998-04-03 SI SI9830678T patent/SI0977576T1/xx unknown
- 1998-04-03 PT PT98917594T patent/PT977576E/pt unknown
- 1998-04-03 CA CA002286719A patent/CA2286719C/en not_active Expired - Fee Related
- 1998-04-03 US US09/402,653 patent/US6329358B1/en not_active Expired - Fee Related
- 1998-04-03 AT AT98917594T patent/ATE269707T1/de active
-
2000
- 2000-04-20 HK HK00102417A patent/HK1025243A1/xx not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05155766A (ja) * | 1991-06-05 | 1993-06-22 | Sigma Tau Ind Farmaceut Riunite Spa | 筋緊張力回復のためのアシル−l−カルニチン医薬組成物 |
WO1995005168A1 (en) * | 1993-08-19 | 1995-02-23 | Shug Austin L | Delayed release carnitine |
Also Published As
Publication number | Publication date |
---|---|
WO1998046233A1 (en) | 1998-10-22 |
PT977576E (pt) | 2004-11-30 |
ES2224380T3 (es) | 2005-03-01 |
EP0977576A1 (en) | 2000-02-09 |
IT1291141B1 (it) | 1998-12-29 |
AU7077498A (en) | 1998-11-11 |
NZ500533A (en) | 2001-03-30 |
ITRM970217A1 (it) | 1998-10-16 |
DK0977576T3 (da) | 2004-11-01 |
ATE269707T1 (de) | 2004-07-15 |
CA2286719C (en) | 2008-06-10 |
EP0977576B1 (en) | 2004-06-23 |
AU730710B2 (en) | 2001-03-15 |
BR9809762A (pt) | 2000-06-20 |
US6329358B1 (en) | 2001-12-11 |
DE69824718D1 (de) | 2004-07-29 |
CA2286719A1 (en) | 1998-10-22 |
DE69824718T2 (de) | 2005-06-30 |
HK1025243A1 (en) | 2000-11-10 |
SI0977576T1 (en) | 2004-10-31 |
KR20010006465A (ko) | 2001-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100368803B1 (ko) | 디하이드에피안드로스테론,유비퀴논및그의치료학적용도 | |
EP0284612B1 (en) | Treatment of bone loss | |
US20020032160A1 (en) | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels | |
JP2001516219A (ja) | 糖尿病患者用医療栄養物 | |
JPH08208490A (ja) | 改良されたカルシウム食事補助組成物 | |
JP2750281B2 (ja) | 高コレステロール血症治療剤 | |
JPH0692847A (ja) | 骨粗鬆症治療剤 | |
US6436946B1 (en) | Xanthine-containing compositions for oral administration and uses related thereto | |
JP2795651B2 (ja) | 新規カルシウム補給剤 | |
US5314919A (en) | Calcium supplements | |
JP2003530349A (ja) | 皮膚病用の使用方法及び皮膚病用薬剤 | |
EP0304986B1 (en) | The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis | |
JP2001520644A (ja) | カルニチン化合物およびdheaまたはdhea−sを含む造骨促進製剤 | |
JPS58131962A (ja) | 新規アミノ酸誘導体の製法 | |
US20030165585A1 (en) | Xanthine-containing compositions for oral administration and uses related thereto | |
US5286490A (en) | Transdermal fluoride medication | |
EP1569635B1 (en) | Use of carnitines for the prevention and/or treatment of disorders caused by the andropause | |
US9974804B1 (en) | Strontium-based composition, product, and method of using the same to control progression of osteoarthritis osteoporosis and tooth decay | |
MXPA01000973A (es) | Un nuevo agente analgesico antiinflamatorio y de cicatrizacion de heridas. | |
CA2082275A1 (en) | Pharmaceutical composition | |
JP2616845B2 (ja) | システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤 | |
JP2948122B2 (ja) | 筋肉タンパク質の形成及び筋肉物質代謝を高めるための医薬品ならびに該医薬品の製法 | |
DE60112802T2 (de) | Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose | |
WO2003049732A1 (en) | Use of 4-androstenediol and 4-androstenediol in a transdermal formulation to increase testosterone levels in humans | |
RU2104012C1 (ru) | Фармацевтическая композиция на основе природного продукта, нормализующая обменные процессы в организме |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050301 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081007 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090107 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090302 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090811 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100706 |